Sat.Feb 27, 2021 - Fri.Mar 05, 2021

Rivals J&J, Merck are latest to team up to boost production of coronavirus vaccines

Bio Pharma Dive

Merck will lend J&J the use of two separate facilities in the unusual agreement, which was brokered by the Biden administration and could help double supply of the one-dose shot

The true cost of COVID-19?

World of DTC Marketing

SUMMARY: COVID-19 has killed many people worldwide, but how many really died from COVID, and how many died because they had an underlying chronic health problem as a major factor? We may never know, but we can not afford to do anything while our population becomes more obese and unhealthy.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Disney characters will lend a hand to kids during MRI scans

Pharma Phorum

Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid.

Researchers receive $1.9 million to study possible dementia causes


Credit: UTHSC Memphis, Tenn. March 2, 2021) – The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.

FDA authorizes J&J's one-shot coronavirus vaccine

Bio Pharma Dive

The agency's emergency clearance makes J&J's vaccine the third available in the U.S., adding much-needed reinforcements at a critical time

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

SUMMARY: According to Pew Internet “Despite antibiotics’ vital role in cancer care, companies have abandoned their development in favor of more profitable drugs.

Johnson & Johnson Will Test its Vaccine in Infants

NY Times

The company’s coming trials will also involve pregnant women and people whose immune systems are compromised. internal-essential Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Immune System Clinical Trials Vaccination and Immunization Babies and Infants Johnson & Johnson

More Trending

A closely watched schizophrenia drug fails key test

Bio Pharma Dive

Though a mid-stage study read out negative, Neurocrine still sees a path forward for the drug, which it licensed from Takeda last summer

Pharma on a digital hiring spree?

World of DTC Marketing

SUMMARY: Almost every pharma company seems to be posting open digital marketing positions on LinkedIn but are they really hiring? A quick check of three open positions found that they “were on hold” due to budget constraints.

One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine

NY Times

Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.

Magnetic whirls in confined spaces


Takeda takes full control of drug for rare epilepsies

Bio Pharma Dive

A new agreement with Ovid Therapeutics has Takeda paying almost $200 million to secure global rights to soticlestat, an experimental treatment for certain brain diseases, including Dravet syndrome and Lennox Gastaut syndrome

Drugs 199

Earning trust and building trust need to occur at the same time

World of DTC Marketing

SUMMARY: Trust is earned every day. Today, because of the Internet, a lot of attention is placed on day-to-day activities. Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines.

ERT Imaging Accelerates Ground-Breaking Research to Improve the Development of Oncology and CNS Treatments


Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management.

NASA scientists complete 1st global survey of freshwater fluctuation


Credit: National Park Service To investigate humans’ impact on freshwater resources, scientists have now conducted the first global accounting of fluctuating water levels in Earth’s lakes and reservoirs – including ones previously too small to measure from space.

Merck withdraws Keytruda in type of lung cancer amid 'industry-wide' review by FDA

Bio Pharma Dive

Since December, three drugmakers have withdrawn immunotherapies from indications previously granted fast-tracked approvals, suggestive of broader FDA concerns


Can J&J’s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7

India's Covaxin Covid-19 Vaccine, Already in Use, Shows Promise in Trials

NY Times

Interim results from clinical trials suggested that Covaxin could be safe and effective, potentially removing one hurdle to New Delhi’s ambitious campaign to inoculate a vast population.

Littlest shop of horrors: Hungry green algae prefer to eat bacteria alive


New study points to potential widespread phagocytosis among green algae, suggests improved methodology in environmental microbiology Credit: N. Bock & E.

The essential audience for well-being

Bio Pharma Dive

For marketers in the health space, cannabis and CBD consumers represent an audience that is in search of both alternative and conventional methods of well-being as their transformation from patient to participant accelerates

phactMI: Delivering accurate drug information to point of care

Pharma R&D Today

Part 1: How healthcare professionals can access the latest and most accurate information on medications. Access to accurate, up-to-date information on medications helps healthcare professionals make better decisions.

Takeda Doubles Down on Ovid Epilepsy Drug in $856 Million Deal


Takeda will develop soticlestat, a first-in-class inhibitor of the enzyme cholesterol 24-hydroxylase (CH24H), as a potential treatment for developmental and epileptic encephalopathies

An unstable working life affects the future mental health of young people


Amgen, with rare buyout, pays $1.9B for cancer biotech Five Prime

Bio Pharma Dive

The acquisition marks a dramatic turnaround for Five Prime, which has in recent years struggled through setbacks, executive departures and layoffs


Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales


Dry eye disease may sound innocuous, but it’s a condition that affects between 25 and 35 percent of individuals in the US, and pandemic-related lifestyle changes may be pushing that percentage up.

Sales 92

Two biotechs target dry eye disease after Novartis’ Xiidra problems

Pharma Phorum

The pipeline for dry eye disease drugs is beginning to heat up, with two biotechs announcing key developments, aiming to disrupt a market led by Allergan and Novartis. Novartis paid Takeda $3.4

Breaking the patrisharky: Scientists reexamine gender biases in shark, ray mating research


Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline

Bio Pharma Dive

The CRISPR biotech raised $115 million in a Series C financing aimed at advancing its engineered cell therapy research

DIH partners with Reha Technology

BioTech 365

DIH partners with Reha Technology DIH partners with Reha Technology A strategic partnership to provide market leading solutions in the lower extremities rehabilitation.

COVAX: Indonesia and the Philippines await AstraZeneca COVID-19 vaccine shipments

BioPharma Reporter

AstraZeneca, through its partnership with the Serum Institute of India, says it is the biggest initial COVID-19 vaccine supplier to COVAX. Markets & Regulations

Protein discovery could help enable eco-friendly fungicides


Findings explain how plants use RNA to defend against fungal invaders Credit: Nicole Ward Gauthier/University of Kentucky New research reveals an essential step in scientists’ quest to create targeted, more eco-friendly fungicides that protect food crops.

RNA 63

Lilly says diabetes shot outperformed rival Novo drug in study

Bio Pharma Dive

The results are a boost for Lilly's drug, tirzepatide, which is being prepared for regulatory submissions later this year. But long-term heart data won't be available for some time

Drugs 160

VirTrial Launches eConsent Solution as Stand-Alone Offering or Bundled With Its Telemedicine Platform


Scottsdale, AZ (March 2, 2021) – VirTrial today announced the general availability of SmartSignals eConsent, a PDF-based, clinical trial consent solution offering rapid implementation and a flexible, scalable, and lightweight design.

Question mark over effectiveness of Pfizer-BioNTech COVID-19 vaccine in obese people

BioPharma Reporter

New data may have serious implications for the development of vaccination strategies for COVID-19, particularly in individuals with obesity. Markets & Regulations

Tissue, scaffold technologies provide new options for breast cancer, other diseases


Credit: Sherry Harbin/Purdue University WEST LAFAYETTE, Ind. – New technology from Purdue University innovators may help improve tissue restoration outcomes for people with breast cancer and other diseases or traumatic injuries.

Lilly drug regrows hair in autoimmune disease study, but safety questions linger

Bio Pharma Dive

The results could help baricitinib become the first treatment for alopecia areata, a leading cause of hair loss. Safety concerns have diminished the drug's prospects in arthritis, however

Drugs 164

Sorrento Gets FDA Go-Ahead to Launch Phase I Study for Nose Drops Against COVID-19


STI-2099 is a formulation of its antibody against COVID-19 that can be taken in a nasal spray. It is also evaluating the antibody in an intravenous form (STI-2020) in a Phase I trial